Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2B and ribavirin for recurrent hepatitis C [6]

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)723-724
Number of pages2
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume19
Issue number6
DOIs
StatePublished - 2004
Externally publishedYes

Fingerprint

Ribavirin
Hepatitis C
Liver Diseases
peginterferon alfa-2b

All Science Journal Classification (ASJC) codes

  • Gastroenterology
  • Hepatology

Cite this

@article{abe4e6430b9448f1ade56aa0fa62e41d,
title = "Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2B and ribavirin for recurrent hepatitis C [6]",
author = "Sandeep Mukherjee",
year = "2004",
doi = "10.1111/j.1440-1746.2004.03452.x",
language = "English",
volume = "19",
pages = "723--724",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2B and ribavirin for recurrent hepatitis C [6]

AU - Mukherjee, Sandeep

PY - 2004

Y1 - 2004

UR - http://www.scopus.com/inward/record.url?scp=3042742732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042742732&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1746.2004.03452.x

DO - 10.1111/j.1440-1746.2004.03452.x

M3 - Letter

VL - 19

SP - 723

EP - 724

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 6

ER -